SCHEMBL19973538

SCHEMBL19973538

CCC(C)OC1CCOc2c(C(=O)Nc3ccc(F)c(F)c3)cccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.40
RAB9A P51151 4/20 0.39
NPC1 O15118 3/20 0.39
HPGD P15428 2/20 0.39
MAOB P27338 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PTGES O14684 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
KCNH2 Q12809 1/20 0.37
HTR2B P41595 1/20 0.37
AKR1C3 P42330 1/20 0.37
NPY2R P49146 2/20 0.37
LMNA P02545 2/20 0.37
MAPT P10636 1/20 0.37
MTTP P55157 1/20 0.37
ALDH1A1 P00352 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19973536 1.00 TP53 (0.40) TP53RAB9ANPC1HPGDMAOB
SCHEMBL19973531 0.85 TP53 (0.45) TP53RAB9ANPC1HPGDMAOB
SCHEMBL19973501 0.84 TP53 (0.37) TP53RAB9ANPC1HPGDMAOB
SCHEMBL19973500 0.84 TP53 (0.37) TP53RAB9ANPC1HPGDMAOB
SCHEMBL19973478 0.82 TP53 (0.43) TP53RAB9ANPC1HPGDMAOB
SCHEMBL19973587 0.82 TP53 (0.43) TP53RAB9ANPC1HPGDMAOB
SCHEMBL19973425 0.80 TP53 (0.47) TP53RAB9ANPC1HPGDMAOB
SCHEMBL19973412 0.80 TP53 (0.47) TP53RAB9ANPC1HPGDMAOB
SCHEMBL19973413 0.80 TP53 (0.47) TP53RAB9ANPC1HPGDMAOB
SCHEMBL21189347 0.80 TP53 (0.40) TP53RAB9ANPC1HPGDMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same ARBUTUS BIOPHARMA CORPORATION (CA) 2021-05-11 US disclosed
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (CA) 2019-07-25 US disclosed
WO-2018052967-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA, INC. (US) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME CBX8, HAVCR2, HCCS TP53 166/4885RAB9A 1393/4885NPC1 983/4885
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same CBX8, HAVCR2, HCCS TP53 166/4885RAB9A 1393/4885NPC1 983/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.